BioCap 2017 – Pre-Conference Workshop and Networking Reception

Event Details

  • Location: Alderley Park, Cheshire
  • Date: Wednesday 27th September 2017

Pharmaceutical Licensing and M&A Strategy – a Transactions Perspective

We are delighted to announce a free afternoon workshop taking place prior to the BioCap Conference on Wednesday 27th September from 4pm, finishing with a networking reception.

The programme (full details below) will focus on deal structures and strategies for the Biotech area, with case studies and speakers representing Big Pharma and Investors.

To register your interest in attending this event please contact

Event Schedule

Wednesday 27th September

3.45pm Registration
4pm Welcome from the Chair
ELAINE EVANS, Chair, Pharmaceutical Licensing Group UK
4.05pm The Pharma Industry Deal Landscape
- Deal trends - licensing v M&A, structures, financials, development status, therapeutic areas
JILL OGDEN, Medius Associates
4.25pm What Big Pharma is Looking For - a Business Development Perspective
- Finding the right opportunities, therapeutics areas, development status, preferred deal structures, due diligence issues
KAY TAIT, Transaction Director, Business Development Operations, AstraZeneca
4.45pm Key Learnings from the Biotech 'Coal Face'
- Deal structures and strategies to build maximal value
IAN NICHOLSON, CEO, F2G/ Operating Partner, Advent Life Sciences
5.05pm Developing Strategies for Optimal Licensing Deal Structures - Thinking into the Future
5.25pm How Public Markets View the Biotech Sector
HITESH THAKRAR, Partner, Syncona Investment Management
5.45pm Networking Reception
6.30pm CLOSE

Venue & Accommodation

Full Venue Address

Alderley Park Conference Centre
Alderley Edge
SK10 4TG

Visit Venue Website